{
    "nctId": "NCT00736333",
    "briefTitle": "A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)",
    "officialTitle": "Observational Program of Caelyx in MBC - Prevention and Treatment of PPE and Infusion Reactions",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasm",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 167,
    "primaryOutcomeMeasure": "Number of Participants With Infusion Reactions (IR)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with metastatic breast cancer\n\nExclusion Criteria:\n\n* History of hypersensitivity to Caelyx or its components\n* Women who are pregnant or breast-feeding\n* Patients with severe myelosuppression",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}